| In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor PL Podolin, BJ Bolognese, JF Foley, E Long III, B Peck, S Umbrecht, ... Prostaglandins & other lipid mediators 104, 25-31, 2013 | 116 | 2013 |
| Implementation and testing of stable, fast implicit solvation in molecular dynamics using the smooth‐permittivity finite difference Poisson–Boltzmann method NV Prabhu, P Zhu, KA Sharp Journal of Computational Chemistry 25 (16), 2049-2064, 2004 | 101 | 2004 |
| An accurate-mass-based spectral-averaging isotope-pattern-filtering algorithm for extraction of drug metabolites possessing a distinct isotope pattern from LC-MS data P Zhu, W Tong, K Alton, S Chowdhury Analytical chemistry 81 (14), 5910-5917, 2009 | 87 | 2009 |
| A retention‐time‐shift‐tolerant background subtraction and noise reduction algorithm (BgS‐NoRA) for extraction of drug metabolites in liquid chromatography/mass spectrometry … P Zhu, W Ding, W Tong, A Ghosal, K Alton, S Chowdhury Rapid Communications in Mass Spectrometry: An International Journal Devoted …, 2009 | 86 | 2009 |
| Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease MK Middleton, AM Zukas, T Rubinstein, M Jacob, P Zhu, L Zhao, I Blair, ... The Journal of experimental medicine 203 (11), 2529-2540, 2006 | 82 | 2006 |
| Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double … W Jurczak, I Moreira, GB Kanakasetty, E Munhoz, MA Echeveste, P Giri, ... The Lancet Haematology 4 (8), e350-e361, 2017 | 81 | 2017 |
| Determination of cellular redox status by stable isotope dilution liquid chromatography/mass spectrometry analysis of glutathione and glutathione disulfide P Zhu, T Oe, IA Blair Rapid Communications in Mass Spectrometry: An International Journal Devoted …, 2008 | 80 | 2008 |
| 15-oxo-Eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferation C Wei, P Zhu, SJ Shah, IA Blair Molecular pharmacology 76 (3), 516-525, 2009 | 73 | 2009 |
| A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis JS Smolen, SB Cohen, HP Tony, M Scheinberg, A Kivitz, A Balanescu, ... Annals of the rheumatic diseases 76 (9), 1598-1602, 2017 | 72 | 2017 |
| Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor BYL719 in patients with … RV Geel, E Elez, JC Bendell, JE Faris, MPJK Lolkema, F Eskens, ... Journal of Clinical Oncology 32 (15_suppl), 3514-3514, 2014 | 62 | 2014 |
| ADME-ENABLING TECHNOLOGIES IN DRUG DESIGN AND DEVELOPMENT D ZHANG, S SURAPANENI | 57 | 2012 |
| Overexpression of Human 15(S)-Lipoxygenase-1 in RAW Macrophages Leads to Increased Cholesterol Mobilization and Reverse Cholesterol Transport GL Weibel, MR Joshi, ET Alexander, P Zhu, IA Blair, GH Rothblat Arteriosclerosis, thrombosis, and vascular biology 29 (6), 837-842, 2009 | 32 | 2009 |
| Characterization of a lipid hydroperoxide-derived RNA adduct in rat intestinal epithelial cells P Zhu, SH Lee, S Wehrli, IA Blair Chemical research in toxicology 19 (6), 809-817, 2006 | 29 | 2006 |
| 12/15-lipoxygenase-dependent myeloid production of interleukin-12 is essential for resistance to chronic toxoplasmosis MK Middleton, AM Zukas, T Rubinstein, M Kinder, EH Wilson, P Zhu, ... Infection and Immunity 77 (12), 5690-5700, 2009 | 24 | 2009 |
| Aztreonam/avibactam effect on pharmacodynamic indices for mutant selection of Escherichia coli and Klebsiella pneumoniae harbouring serine- and New Delhi … K Feng, N Jia, P Zhu, S Sy, Y Liu, D Dong, S Zhu, J Zhang, Y Liu, ... Journal of Antimicrobial Chemotherapy 76 (11), 2875-2883, 2021 | 21 | 2021 |
| Development of a semi-automated LC/MS/MS method for the simultaneous quantitation of 14, 15-epoxyeicosatrienoic acid, 14, 15-dihydroxyeicosatrienoic acid, leukotoxin and … P Zhu, B Peck, H Licea-Perez, JF Callahan, C Booth-Genthe Journal of Chromatography B 879 (25), 2487-2493, 2011 | 20 | 2011 |
| Physiologically based pharmacokinetic‐pharmacodynamic evaluation of meropenem plus fosfomycin in paediatrics FS Martins, P Zhu, MT Heinrichs, SKB Sy British Journal of Clinical Pharmacology 87 (3), 1012-1023, 2021 | 18 | 2021 |
| Population pharmacokinetics–pharmacodynamics of oral everolimus in patients with seizures associated with tuberous sclerosis complex FP Combes, G Baneyx, N Coello, P Zhu, W Sallas, H Yin, J Nedelman Journal of Pharmacokinetics and Pharmacodynamics 45, 707-719, 2018 | 17 | 2018 |
| Pharmacodynamic evaluation of suppression of in vitro resistance in Acinetobacter baumannii strains using polymyxin B-based combination therapy NH Fedrigo, DR Shinohara, J Mazucheli, SAB Nishiyama, ... Scientific Reports 11 (1), 11339, 2021 | 15 | 2021 |
| Prediction of tissue exposures of Meropenem, Colistin, and Sulbactam in pediatrics using physiologically based pharmacokinetic modeling S Zhu, J Zhang, Z Lv, P Zhu, C Oo, M Yu, SKB Sy Clinical Pharmacokinetics 61 (10), 1427-1441, 2022 | 12 | 2022 |
Ian A. BlairA.N. Richards Professor of Systems Pharmacology在 mail.med.upenn.edu 的电子邮件经过验证
